• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Phage Therapy for Orthopaedic Infections: The First Three Cases from the United Kingdom.用于骨科感染的噬菌体疗法:来自英国的前三例病例
Antibiotics (Basel). 2025 Jan 22;14(2):114. doi: 10.3390/antibiotics14020114.
2
Potential of training of anti- therapeutic phages against multidrug-resistant isolates is restricted by inter- and intra-sequence type specificity.针对多药耐药分离株的抗治疗性噬菌体的培养潜力受到种间和种内序列特异性的限制。
mSystems. 2024 Oct 22;9(10):e0085024. doi: 10.1128/msystems.00850-24. Epub 2024 Sep 9.
3
Phages against Noncapsulated Klebsiella pneumoniae: Broader Host range, Slower Resistance.噬菌体对抗无荚膜肺炎克雷伯菌:宿主范围更广,耐药性发展更慢。
Microbiol Spectr. 2023 Aug 17;11(4):e0481222. doi: 10.1128/spectrum.04812-22. Epub 2023 Jun 20.
4
Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.从 COVID-19 患者呼吸机相关性肺炎(VAP)感染中分离的产碳青霉烯酶肺炎克雷伯菌(CRKP)中分离、鉴定、治疗效力及新型噬菌体 vB_KshKPC-M 的基因组分析。
Ann Clin Microbiol Antimicrob. 2023 Feb 24;22(1):18. doi: 10.1186/s12941-023-00567-1.
5
Isolation and characterization of lytic bacteriophages from sewage at an egyptian tertiary care hospital against methicillin-resistant clinical isolates.从埃及一家三级护理医院的污水中分离并鉴定针对耐甲氧西林临床分离株的裂解性噬菌体。
Saudi J Biol Sci. 2022 May;29(5):3097-3106. doi: 10.1016/j.sjbs.2022.03.019. Epub 2022 Mar 19.
6
Phenotypic and Genotypic Characterization of Novel Polyvalent Bacteriophages With Potent Activity Against an International Collection of Genetically Diverse .新型多价噬菌体的表型和基因型特征及其对具有遗传多样性的国际噬菌体的强效活性
Front Cell Infect Microbiol. 2021 Jul 6;11:698909. doi: 10.3389/fcimb.2021.698909. eCollection 2021.
7
Phage Therapy: A Promising Treatment Strategy against Infections Caused by Multidrug-resistant .噬菌体疗法:一种针对多重耐药菌感染的有前景的治疗策略
Curr Pharm Des. 2025;31(13):1007-1019. doi: 10.2174/0113816128343976241117183624.
8
[Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].[引起复杂性皮肤和软组织感染的多重耐药病原体对标准噬菌体鸡尾酒疗法的敏感性]
Mikrobiyol Bul. 2016 Apr;50(2):215-23. doi: 10.5578/mb.24165.
9
Injectable Phage-Loaded Microparticles Effectively Release Phages to Kill Methicillin-Resistant .可注射噬菌体负载微球能有效地释放噬菌体来杀死耐甲氧西林金黄色葡萄球菌
ACS Appl Mater Interfaces. 2024 Apr 10;16(14):17232-17241. doi: 10.1021/acsami.3c19443. Epub 2024 Mar 30.
10
Phage Therapy for Diabetic Foot Infection: A Case Series.噬菌体治疗糖尿病足感染:病例系列。
Clin Ther. 2023 Aug;45(8):797-801. doi: 10.1016/j.clinthera.2023.06.009. Epub 2023 Jul 11.

引用本文的文献

1
Current Applications and the Future of Phage Therapy for Periprosthetic Joint Infections.噬菌体疗法在人工关节感染中的当前应用及未来发展
Antibiotics (Basel). 2025 Jun 6;14(6):581. doi: 10.3390/antibiotics14060581.
2
Preparation and pharmacokinetic evaluation of Staphylococcus phage COP-80B for treatment of periprosthetic joint infections in a mouse model.用于治疗小鼠模型假体周围关节感染的葡萄球菌噬菌体COP-80B的制备及药代动力学评价
Virus Res. 2025 Jul;357:199592. doi: 10.1016/j.virusres.2025.199592. Epub 2025 May 31.
3
Bacteriophages as potential therapeutic agents in the control of bacterial infections.噬菌体作为控制细菌感染的潜在治疗剂。
EXCLI J. 2025 Mar 31;24:524-526. doi: 10.17179/excli2025-8145. eCollection 2025.

本文引用的文献

1
Bacteriophage therapy as an innovative strategy for the treatment of Periprosthetic Joint Infection: a systematic review.噬菌体治疗作为一种治疗人工关节感染的创新策略:系统评价。
Int Orthop. 2024 Nov;48(11):2809-2825. doi: 10.1007/s00264-024-06295-1. Epub 2024 Sep 10.
2
Phage Therapy as a Novel Therapeutic for the Treatment of Bone and Joint Infections.噬菌体疗法作为一种治疗骨与关节感染的新型疗法。
Clin Infect Dis. 2023 Nov 2;77(Suppl 5):S407-S415. doi: 10.1093/cid/ciad533.
3
Phage Therapy for Diabetic Foot Infection: A Case Series.噬菌体治疗糖尿病足感染:病例系列。
Clin Ther. 2023 Aug;45(8):797-801. doi: 10.1016/j.clinthera.2023.06.009. Epub 2023 Jul 11.
4
Isolation and characterization of novel phages for therapeutic applications.用于治疗应用的新型噬菌体的分离与鉴定。
Front Cell Infect Microbiol. 2023 May 24;13:1169135. doi: 10.3389/fcimb.2023.1169135. eCollection 2023.
5
Phage therapy: From biological mechanisms to future directions.噬菌体疗法:从生物学机制到未来方向。
Cell. 2023 Jan 5;186(1):17-31. doi: 10.1016/j.cell.2022.11.017.
6
The Safety and Efficacy of Phage Therapy: A Systematic Review of Clinical and Safety Trials.噬菌体疗法的安全性与有效性:临床及安全性试验的系统评价
Antibiotics (Basel). 2022 Sep 30;11(10):1340. doi: 10.3390/antibiotics11101340.
7
Experience Using Adjuvant Bacteriophage Therapy for the Treatment of 10 Recalcitrant Periprosthetic Joint Infections: A Case Series.辅助噬菌体治疗难治性人工关节周围感染 10 例的临床应用:病例系列研究。
Clin Infect Dis. 2023 Feb 8;76(3):e1463-e1466. doi: 10.1093/cid/ciac694.
8
Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.噬菌体治疗分枝杆菌感染:20 例耐药分枝杆菌病患者中噬菌体的同情使用。
Clin Infect Dis. 2023 Jan 6;76(1):103-112. doi: 10.1093/cid/ciac453.
9
Bacteriophage-Mediated Control of Biofilm: A Promising New Dawn for the Future.噬菌体介导的生物膜控制:未来充满希望的新曙光。
Front Microbiol. 2022 Apr 4;13:825828. doi: 10.3389/fmicb.2022.825828. eCollection 2022.
10
Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.噬菌体治疗难治性感染的安全性和疗效:系统评价。
Lancet Infect Dis. 2022 Aug;22(8):e208-e220. doi: 10.1016/S1473-3099(21)00612-5. Epub 2022 Mar 3.

用于骨科感染的噬菌体疗法:来自英国的前三例病例

Phage Therapy for Orthopaedic Infections: The First Three Cases from the United Kingdom.

作者信息

Munteanu Daniela I, Dunn John, Apjok Gábor, Kintses Bálint, Griselain Johann, Steurs Griet, Cochez Christel, Djebara Sarah, Merabishvili Maya, Pirnay Jean-Paul, Štilec Vida, Peterka Matjaž, Simpson Emily A, Downie Samantha, MacInnes Alasdair, Nicol Graeme, Clift Benedict, Jones Joshua D

机构信息

Department of Medical Microbiology, Ninewells Hospital, Dundee DD1 9SY, UK.

Pharmacy Department, Ninewells Hospital, Dundee DD1 9SY, UK.

出版信息

Antibiotics (Basel). 2025 Jan 22;14(2):114. doi: 10.3390/antibiotics14020114.

DOI:10.3390/antibiotics14020114
PMID:40001358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11851713/
Abstract

: Bacteriophages (phages) are viruses that infect and kill bacteria. The antimicrobial resistance crisis has driven renewed interest in phage therapy, including the use of phages to treat chronic orthopaedic infections. : Here, we present the results of the first three orthopaedic patients treated with phage therapy in the United Kingdom. : The first patient was treated in May 2023 and received phages active against . At nine months follow-up, the patient's wound remained healed, the C-reactive protein normal and the patient was walking independently. The second patient received phages active against and ; the infection remained unresolved. The third patient received phages active against ; at six months follow-up, the patient was free of infection. Endotoxin was considered at least partially responsible for mild self-limiting adverse effects in two cases. : These promising results hint at the potential for phage therapy to transform the care of chronic orthopaedic infections.

摘要

噬菌体是感染并杀死细菌的病毒。抗菌药物耐药性危机重新激发了人们对噬菌体疗法的兴趣,包括使用噬菌体治疗慢性骨科感染。在此,我们展示了英国首批三名接受噬菌体疗法的骨科患者的治疗结果。第一名患者于2023年5月接受治疗,接受了对……有活性的噬菌体。在九个月的随访中,患者的伤口保持愈合,C反应蛋白正常,患者能够独立行走。第二名患者接受了对……和……有活性的噬菌体;感染仍未解决。第三名患者接受了对……有活性的噬菌体;在六个月的随访中,患者没有感染。内毒素被认为至少部分导致了两例轻度自限性不良反应。这些有前景的结果暗示了噬菌体疗法改变慢性骨科感染治疗的潜力。